abstract |
The present invention relates to compounds that are hepatitis B virus (HBV) inhibitors. The compounds of the present invention are useful alone or in combination with other agents for treating, ameliorating, blocking or curing HBV infection and related conditions. The present invention also relates to a pharmaceutical composition comprising the compound. |